AIP
KYMR icon

Ameritas Investment Partners’s Kymera Therapeutics KYMR Stock Holding History

Ameritas Investment Partners’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$388K Hold
4,663
– – 0.01% 921
2025
Q4 		$363K Buy
4,663
+450
+11% +$30.4K 0.01% 936
2025
Q3 		$238K Sell
4,213
-699
-14% -$31.5K 0.01% 1135
2025
Q2 		$214K Hold
4,912
– – 0.01% 1251
2025
Q1 		$134K Hold
4,912
– – ﹤0.01% 1505
2024
Q4 		$198K Buy
4,912
+406
+9% +$18.3K 0.01% 1329
2024
Q3 		$213K Buy
4,506
+436
+11% +$19.3K 0.01% 1277
2024
Q2 		$121K Hold
4,070
– – ﹤0.01% 1609
2024
Q1 		$164K Buy
4,070
+295
+8% +$10.6K 0.01% 1429
2023
Q4 		$96.1K Hold
3,775
– – ﹤0.01% 1758
2023
Q3 		$52.5K Buy
3,775
+810
+27% +$16.3K ﹤0.01% 2079
2023
Q2 		$68.2K Hold
2,965
– – ﹤0.01% 1851
2023
Q1 		$87.9K Hold
2,965
– – ﹤0.01% 1618
2022
Q4 		$105K Hold
2,965
– – ﹤0.01% 1559
2022
Q3 		$64K Buy
2,965
+331
+13% +$8.72K ﹤0.01% 1809
2022
Q2 		$51K Hold
2,634
– – ﹤0.01% 1975
2022
Q1 		$111K Hold
2,634
– – ﹤0.01% 1572
2021
Q4 		$167K Hold
2,634
– – 0.01% 1338
2021
Q3 		$155K Buy
2,634
+367
+16% +$21.3K 0.01% 1400
2021
Q2 		$110K Buy
2,267
+1,422
+168% +$61.7K ﹤0.01% 1668
2021
Q1 		$33K Hold
845
– – ﹤0.01% 2316
2020
Q4 		$52K Buy
+845
New +$41.2K ﹤0.01% 1972

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Ameritas Investment Partners's KYMR Position: Q1 2026 in Review

Ameritas Investment Partners held its Kymera Therapeutics (KYMR) position steady in Q1 2026 at 4,663 shares worth $388K. The position accounts for 0.01% of the portfolio, ranked #921.

Ameritas Investment Partners first reported a position in KYMR in Q4 2020 and has held it in 22 quarters since. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Ameritas Investment Partners held 4,663 shares of Kymera Therapeutics worth $388K as of Q1 2026.
  • Ameritas Investment Partners left its Kymera Therapeutics share count unchanged in Q1 2026.
  • Kymera Therapeutics made up 0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #921 holding.
  • Ameritas Investment Partners first reported a position in Kymera Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.